Intensification of Basal Insulin Therapy with Lixisenatide in Patients with Type 2 Diabetes in a Real-World Setting: The BASAL-LIXI Study

BACKGROUND: Basal insulin reduces fasting blood glucose levels, but postprandial blood glucose levels may remain higher. Traditional strategies with rapid insulin intensification can cause hypoglycemic episodes and weight gain. Glucagon-like peptide-1 receptor agonists, such as the short-acting lixi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellido, Diego, Abellán, Pablo, Ruiz Palomar, José Manuel, Álvarez Sintes, Rogelio, Nubiolae, Andreu, Bellido, Virginia, Romero, Gracia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218842/
https://www.ncbi.nlm.nih.gov/pubmed/30455779
http://dx.doi.org/10.1016/j.curtheres.2018.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218842/
https://www.ncbi.nlm.nih.gov/pubmed/30455779
http://dx.doi.org/10.1016/j.curtheres.2018.09.001

Ejemplares similares